Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Generalized Myasthenia Gravis
Related studies linked through entity extraction aliases.
Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Status
- RECRUITING
- Phase
- N/A
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
- Status
- RECRUITING
- Phase
- PHASE1
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- Status
- RECRUITING
- Phase
- PHASE2
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE3
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE3
Seronegative Myasthenia Gravis - Efgartigimod IV
- Status
- RECRUITING
- Phase
- PHASE3
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3